Many lines of evidence have indicated that overexpression of CUX1 was present in various types of cancers, such as melanoma, pancreatic cancer, multiple myeloma, and breast cancer (Fan et al., 2014; Vadnais et al., 2014; Krug et al., 2020). Here, CUX1 is linked to breast cancer.